BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 1605660)

  • 1. Oral Ciprofloxacin Prophylaxis in Patients Undergoing High DoseTherapy and Autologous Hematopoietic Stem Cell Transplantation.
    Tabarraee M; Tavakoli-Ardakani M; Mehdizadeh M; Ghadiani M; Rezvani H; Hajifathali A; Khamsi S
    Iran J Pharm Res; 2016; 15(Suppl):159-163. PubMed ID: 28228813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
    Gafter-Gvili A; Fraser A; Paul M; Vidal L; Lawrie TA; van de Wetering MD; Kremer LC; Leibovici L
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD004386. PubMed ID: 22258955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-cancer effects of quinolone antibiotics?
    Paul M; Gafter-Gvili A; Fraser A; Leibovici L
    Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):825-31. PubMed ID: 17701431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract.
    Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ
    Scand J Infect Dis Suppl; 1986; 48():66-78. PubMed ID: 3535055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation.
    Menichetti F; Felicini R; Bucaneve G; Aversa F; Greco M; Pasquarella C; Moretti MV; Del Favero A; Martelli MF
    Bone Marrow Transplant; 1989 Sep; 4(5):489-92. PubMed ID: 2790326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of gram-negative bacterial infection in granulocytopenic patients: a randomized study comparing oral norfloxacin with gentamycin.
    Nemet D; Kalenic S; Badanjak A; Bogdanic V; Davila N; Francetić I; Labar B
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():105. PubMed ID: 2697389
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients.
    D'Antonio D; Iacone A; Fioritoni G; Betti S; Dell'Isola M; Quaglietta AM; Accorsi P; Pantalone V; Recchia A; Piergallini A
    Drugs Exp Clin Res; 1992; 18(4):141-6. PubMed ID: 1451644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparison of nystatin with norfloxacin for prevention of infection after consolidation therapy in patients with acute leukemia or autologous bone marrow transplantation: a randomized study].
    Sampi K; Maseki N; Hattori M
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):823-6. PubMed ID: 1605660
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.